Advancing performance measures for use of medications in substance abuse treatment - Test2 - elhamkhani - TriplyDB

Advancing performance measures for use of medications in substance abuse treatment

Advancing performance measures for use of medications in substance abuse treatment

http://www.wikidata.org/entity/Q28744415

about

Performance measures for substance use disorders--what research is needed?A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment Financial factors and the implementation of medications for treating opioid use disorders.Prescription of topiramate to treat alcohol use disorders in the Veterans Health Administration Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care.Establishing the feasibility of measuring performance in use of addiction pharmacotherapy.The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.A demonstration project implementing extended-release naltrexone in Los Angeles County.Adherence to Buprenorphine Treatment Guidelines in a Medicaid Program.Treatment preferences among problem drinkers in primary care.The primitive state of quality measures in addiction treatment and their application.

P2860

Q28709224-3357871D-477C-4A7E-A322-BF7E85D14267 Q35075932-DE63A794-1538-48C4-A29F-372730EE2233 Q35243514-AAB8B0DC-492B-4BE4-87CA-8A7BA2F5AD7A Q36192673-8AE7661E-F790-408F-B283-C790DE6FBCEB Q36364490-0D314336-25C4-4F7E-A2EC-31FF7DEE428C Q36381418-EC928989-DAD2-4BE8-B4E7-111BA660EB41 Q37028407-49181D60-3FE9-4295-AA07-C093615DACDD Q37210855-472306D1-552F-4C15-8C0E-FF7A7DADBE70 Q37638165-E749DB04-DD91-4870-B750-42928FD18B5C Q37729027-03EED9A2-3C11-47A3-AA7D-3C25DBB256EF Q38986525-127C2244-349B-4B26-B228-1368FBB7C9A3 Q41367554-F83FF59E-F708-43DC-A0D1-3C68161F4AEF Q47743939-0DECB822-F69F-4158-B40B-1F7DDFE09BF4 Q52307850-0F3E357D-EF2C-4771-9630-74CDB115AB02

P2860

Advancing performance measures for use of medications in substance abuse treatment

http://www.wikidata.org/entity/Q28744415

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Advancing performance measures for use of medications in substance abuse treatment

@ast

Advancing performance measures for use of medications in substance abuse treatment

@en

Advancing performance measures for use of medications in substance abuse treatment

@nl

type

label

Advancing performance measures for use of medications in substance abuse treatment

@ast

Advancing performance measures for use of medications in substance abuse treatment

@en

Advancing performance measures for use of medications in substance abuse treatment

@nl

prefLabel

Advancing performance measures for use of medications in substance abuse treatment

@ast

Advancing performance measures for use of medications in substance abuse treatment

@en

Advancing performance measures for use of medications in substance abuse treatment

@nl

P1433

Q28744415-C2C8D39D-12EE-4105-BC71-C0C322BA7F5D

P1476

Q28744415-3E9CFDDE-A2A3-467A-B8EE-DBCD4257680D

P2093

Q28744415-0302C121-5DD9-42A8-8AB2-DAFBF0195827

Q28744415-044100FF-87C9-4F9B-80B8-14C106B95997

Q28744415-2FD73066-2D60-4D33-95B5-19965F5D1661

Q28744415-630A9DB2-5D14-4442-B34A-207277096863

Q28744415-63F423F0-3B8E-44C4-96C2-A4418DD08465

Q28744415-8435D65E-8E21-4A4D-A014-B59E82EBF36F

Q28744415-92E0EDFE-D1BB-4D10-92FC-F426C9E735B3

Q28744415-A3C32559-649C-4031-B3CE-2E797BC027F6

Q28744415-A6A25488-99B2-49B5-BAA6-FF4F1B7D6CA0

Q28744415-A9BA1E1B-7136-470A-B005-925B6EBD0000

P2860

Q28744415-04B7D93A-D535-425B-8774-5B96A127CE1F

Q28744415-05FD2489-26DD-451E-9231-25979D96CCD2

Q28744415-0C9494F7-7948-4EB8-95B3-102F14D7BA83

Q28744415-123F887B-F85A-4313-B944-915B87B5DCC5

Q28744415-1C0303B2-4BAF-4C0A-8D99-430FE5703C15

Q28744415-2A3C4BCB-E47E-4C3B-92AB-AC4E8667433E

Q28744415-2C019464-BEB6-4A9F-BEBD-3CB19FB4CA0C

Q28744415-2CD4FF0D-687C-4435-8E9C-4BC13FF2BC9A

Q28744415-2DBE32DC-DE9D-40A3-BD33-EFFA368D5BD8

Q28744415-34318802-2D3A-410C-A876-A291ADE11605

P304

Q28744415-770F97FD-C054-49E0-B098-81F2891E957E

P31

Q28744415-C960C927-83C6-42DF-B238-7DE35F26F725

P356

Q28744415-59F5F96A-C44D-490D-B8E8-1338B64100D4

P407

Q28744415-3E339A9C-4CEF-45B9-AE01-9C377FA90F45

P433

Q28744415-524528B9-0716-4AF5-9DF8-86A0E43460E9

P478

Q28744415-D30FA239-B71B-4B01-9F2F-F49F387A8721

P50

Q28744415-F9F2E8B7-3F95-4273-94D2-EE2AA4E0CDF8

P577

Q28744415-CB332FDD-735A-403C-A337-639073582169

P5875

Q28744415-77AFCB3A-6B82-4A74-AF5C-C36C02075907

P698

Q28744415-6DB5EA21-7128-46B9-98AE-69C53CF8B991

P932

Q28744415-E058292C-2FA2-4988-B924-1798B3C3CBD3

P356

J.JSAT.2010.08.005

P1433

Journal of Substance Abuse Treatment

P1476

Advancing performance measures for use of medications in substance abuse treatment

@en

P2093

Alex H S Harris

http://www.w3.org/2001/XMLSchema#string

Amanda Gmyrek

http://www.w3.org/2001/XMLSchema#string

Constance M Horgan

http://www.w3.org/2001/XMLSchema#string

David R Gastfriend

http://www.w3.org/2001/XMLSchema#string

Deborah W Garnick

http://www.w3.org/2001/XMLSchema#string

Frank McCorry

http://www.w3.org/2001/XMLSchema#string

Henrick J Harwood

http://www.w3.org/2001/XMLSchema#string

Huong Un

http://www.w3.org/2001/XMLSchema#string

James Thatcher

http://www.w3.org/2001/XMLSchema#string

Joann Albright

http://www.w3.org/2001/XMLSchema#string

P2860

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

Public reporting and pay for performance in hospital quality improvement

Barriers to the use of medications to treat alcoholism.

Launching HITECH.

Creating new realities: program development and dissemination

The quality of care. How can it be assessed?

Electronic health records in ambulatory care--a national survey of physicians.

Lessons from five states: public sector use of the Washington Circle performance measures.

Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty

The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters

P304

35-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JSAT.2010.08.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47384034

http://www.w3.org/2001/XMLSchema#string

P698

20934836

http://www.w3.org/2001/XMLSchema#string

P932

2997925

http://www.w3.org/2001/XMLSchema#string